{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:20:12Z","timestamp":1791199212274,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antiretroviral therapy (ART) to treat and pre-exposure prophylaxis (PrEP) to prevent HIV infection are effective tools to help end the HIV epidemic. However, their use could affect HIV transfusion-transmission risk. Three different ART\/PrEP prevalence analyses in blood donors were conducted. First, blood samples from HIV-positive and a comparison group of infection-nonreactive donors were tested under blind using liquid chromatography-tandem mass spectrometry for ART. Second, blood donor samples from infection-nonreactive, 18- to 45-year-old, male, first-time blood donors in 6 US locations were tested for emtricitabine and tenofovir. Third, in men who have sex with men (MSM) participating in the 2017 Centers for Disease Control and Prevention National HIV Behavioral Surveillance (NHBS) from 5 US cities, self-reported PrEP use proximate to donation was assessed. In blind testing, no ART was detected in 300 infection-nonreactive donor samples, but in 299 HIV confirmed-infected donor samples, 46 (15.4%; 95% confidence interval [CI], 11.5% to 20.0%) had evidence of ART. Of the 1494 samples tested from first-time male donors, 9 (0.6%; 95% CI, 0.03% to 1.1%) had tenofovir and emtricitabine. In the NHBS MSM survey, 27 of 591 respondents (4.8%; 95% CI, 3.2% to 6.9%) reported donating blood in 2016 or 2017 and PrEP use within the same time frame as blood donation. Persons who are HIV positive and taking ART and persons taking PrEP to prevent HIV infection are donating blood. Both situations could lead to increased risk of HIV transfusion transmission if blood screening assays are unable to detect HIV in donations from infected donors.<\/jats:p>","DOI":"10.1182\/blood.2020006890","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T19:00:04Z","timestamp":1594321204000},"page":"1351-1358","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern"],"prefix":"10.1182","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6251-366X","authenticated-orcid":false,"given":"Brian","family":"Custer","sequence":"first","affiliation":[{"name":"Vitalant Research Institute, San Francisco, CA;"},{"name":"Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Quiner","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, CA;"},{"name":"RTI International, Research Triangle Park, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8165-3879","authenticated-orcid":false,"given":"Richard","family":"Haaland","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, US Centers for Disease Control and Prevention, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, US Centers for Disease Control and Prevention, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5619-2767","authenticated-orcid":false,"given":"Mars","family":"Stone","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, CA;"},{"name":"Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Reik","sequence":"additional","affiliation":[{"name":"OneBlood, St. Petersburg, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-3115","authenticated-orcid":false,"given":"Whitney R.","family":"Steele","sequence":"additional","affiliation":[{"name":"Scientific Affairs, American Red Cross, Rockville, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Kessler","sequence":"additional","affiliation":[{"name":"New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip C.","family":"Williamson","sequence":"additional","affiliation":[{"name":"Creative Testing Solutions, Tempe, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Anderson","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration, Silver Spring, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Williams","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration, Silver Spring, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Raymond","sequence":"additional","affiliation":[{"name":"School of Public Health, Rutgers University, Piscataway, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-5660","authenticated-orcid":false,"given":"Willi","family":"McFarland","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Louisiana Department of Health, New Orleans, LA;"},{"name":"Louisiana State University Health Sciences Center, New Orleans, LA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Glick","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington, Public Health\u2013Seattle & King County, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwa","family":"Sey","sequence":"additional","affiliation":[{"name":"Los Angeles Department of Health, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. David","family":"Melton","sequence":"additional","affiliation":[{"name":"Georgia Department of Public Health, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Glynn","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[{"name":"Scientific Affairs, American Red Cross, Gaithersburg, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1446-125X","authenticated-orcid":false,"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, CA;"},{"name":"Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"suppl 1","key":"2020091011281691300_B1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/voxs.12136","article-title":"Testing for HIV\u2014the first three decades","volume":"10","author":"Busch","year":"2015","journal-title":"ISBT Sci Ser"},{"issue":"1","key":"2020091011281691300_B2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciw666","article-title":"Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure","volume":"64","author":"Delaney","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"2020091011281691300_B3","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jcv.2011.09.011","article-title":"Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections","volume":"52","author":"Masciotra","year":"2011","journal-title":"J Clin Virol"},{"issue":"17","key":"2020091011281691300_B4","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2018-11-833996","article-title":"Prevention of transfusion-transmitted infections","volume":"133","author":"Busch","year":"2019","journal-title":"Blood"},{"issue":"6","key":"2020091011281691300_B5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/trf.13024","article-title":"Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions","volume":"55","author":"Bruhn","year":"2015","journal-title":"Transfusion"},{"issue":"11","key":"2020091011281691300_B6","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1537-2995.2009.02322.x","article-title":"Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion","volume":"49","author":"Kleinman","year":"2009","journal-title":"Transfusion"},{"issue":"9","key":"2020091011281691300_B7","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/trf.12769","article-title":"First report of human immunodeficiency virus transmission via a blood donation that tested negative by 20-minipool nucleic acid amplification in Japan","volume":"54","author":"Sobata","year":"2014","journal-title":"Transfusion"},{"issue":"6","key":"2020091011281691300_B8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/vox.12790","article-title":"Undetectable does not equal untransmittable for HIV and blood transfusion","volume":"114","author":"Gosbell","year":"2019","journal-title":"Vox Sang"},{"issue":"5","key":"2020091011281691300_B9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/vox.12516","article-title":"Blood safety implications of donors using HIV pre-exposure prophylaxis","volume":"112","author":"Seed","year":"2017","journal-title":"Vox Sang"},{"issue":"5","key":"2020091011281691300_B10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"2020091011281691300_B11","doi-asserted-by":"crossref","first-page":"j5011","DOI":"10.1136\/bmj.j5011","article-title":"Recent advances in pre-exposure prophylaxis for HIV","volume":"359","author":"Desai","year":"2017","journal-title":"BMJ"},{"issue":"9","key":"2020091011281691300_B12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"10189","key":"2020091011281691300_B13","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study","volume":"393","author":"Rodger","year":"2019","journal-title":"Lancet"},{"key":"2020091011281691300_B14","author":"Centers for Disease Control and Prevention","year":"2018"},{"issue":"3","key":"2020091011281691300_B15","doi-asserted-by":"crossref","first-page":"e25461","DOI":"10.1002\/jia2.25461","article-title":"National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017","volume":"23","author":"Sullivan","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"2020091011281691300_B16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.2018.21167","article-title":"HIV viral load and transmissibility of HIV infection: Undetectable Equals Untransmittable","volume":"321","author":"Eisinger","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"2020091011281691300_B17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/ciw365","article-title":"Initiation of antiretroviral therapy during acute HIV-1 infection leads to a high rate of nonreactive HIV serology","volume":"63","author":"de Souza","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2020091011281691300_B18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","article-title":"Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection","volume":"24","author":"Colby","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"2020091011281691300_B19","doi-asserted-by":"crossref","first-page":"e1002417","DOI":"10.1371\/journal.pmed.1002417","article-title":"HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study","volume":"14","author":"Henrich","year":"2017","journal-title":"PLoS Med"},{"issue":"14","key":"2020091011281691300_B20","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1097\/QAD.0000000000001577","article-title":"The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion","volume":"31","author":"Donnell","year":"2017","journal-title":"AIDS"},{"issue":"8","key":"2020091011281691300_B21","doi-asserted-by":"crossref","first-page":"ofy180","DOI":"10.1093\/ofid\/ofy180","article-title":"A strategy for PrEP clinicians to manage ambiguous HIV test results during follow-up visits","volume":"5","author":"Smith","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"27","key":"2020091011281691300_B22","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.1073\/pnas.1501443112","article-title":"Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial","volume":"112","author":"Kuebler","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2020091011281691300_B23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QAI.0000000000000919","article-title":"Regulatory T-cell activity but not conventional HIV-specific T-cell responses are associated with protection from HIV-1 infection","volume":"72","author":"Pattacini","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2020091011281691300_B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/trf.15646","article-title":"Donor compliance research: what are you thinking?","volume":"60","author":"Custer","year":"2020","journal-title":"Transfusion"},{"issue":"6 Pt 2","key":"2020091011281691300_B25","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/trf.13632","article-title":"Transfusion-transmissible infection monitoring system: a tool to monitor changes in blood safety","volume":"56","author":"Custer","year":"2016","journal-title":"Transfusion"},{"key":"2020091011281691300_B26","author":"US Food and Drug Administration","year":"2015"},{"key":"2020091011281691300_B27","author":"US Food and Drug Administration","year":"2020"},{"issue":"9","key":"2020091011281691300_B28","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2105\/AJPH.2019.305172","article-title":"Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States","volume":"109","author":"Siegler","year":"2019","journal-title":"Am J Public Health"},{"key":"2020091011281691300_B29","unstructured":"AIDSVU\n          . ZIP Code, Community Area\/Ward, Census Tract; 2018. https:\/\/aidsvu.org\/data-methods\/data-methods-zip-code-census-tract\/. Accessed 25 July 2018."},{"issue":"suppl 1","key":"2020091011281691300_B30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/00333549071220S107","article-title":"Surveillance of HIV risk and prevention behaviors of men who have sex with men\u2013a national application of venue-based, time-space sampling","volume":"122","author":"MacKellar","year":"2007","journal-title":"Public Health Rep"},{"issue":"5","key":"2020091011281691300_B31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/ciw367","article-title":"Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men\u201420 US cities, 2014","volume":"63","author":"Hoots","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2020091011281691300_B32","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/infdis\/jiv500","article-title":"Age-specific race and ethnicity disparities in HIV infection and awareness among men who have sex with men\u201420 US Cities, 2008-2014","volume":"213","author":"Wejnert","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"2020091011281691300_B33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COH.0000000000000209","article-title":"Should we fear resistance from tenofovir\/emtricitabine preexposure prophylaxis?","volume":"11","author":"Parikh","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"2020091011281691300_B34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QAI.0000000000000921","article-title":"Brief Report: HIV-1 evolution in breakthrough infections in a human trial of oral pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate","volume":"72","author":"Ruone","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2020091011281691300_B35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QAD.0000000000000915","article-title":"Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation","volume":"30","author":"Weis","year":"2016","journal-title":"AIDS"},{"issue":"12","key":"2020091011281691300_B36","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV preexposure prophylaxis: a review","volume":"319","author":"Riddell","year":"2018","journal-title":"JAMA"},{"key":"2020091011281691300_B37","article-title":"HIV preexposure prophylaxis: the role of primary care clinicians in ending the HIV epidemic","author":"Khalili","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2020091011281691300_B38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/526786","article-title":"Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy","volume":"197","author":"Pereyra","year":"2008","journal-title":"J Infect Dis"},{"key":"2020091011281691300_B39","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.celrep.2019.03.097","article-title":"Comprehensive profiling of HIV antibody evolution","volume":"27","author":"Eshleman","year":"2019","journal-title":"Cell Rep"},{"issue":"10","key":"2020091011281691300_B40","doi-asserted-by":"crossref","first-page":"e00757","DOI":"10.1128\/JCM.00757-19","article-title":"Decreased seroreactivity in individuals initiating antiretroviral therapy during acute HIV infection","volume":"57","author":"Manak","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2020091011281691300_B41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/infdis\/jiz145","article-title":"Discovery of \u201cfalse elite controllers\u201d: HIV antibody-positive RNA-negative blood donors found to be on antiretroviral treatment","volume":"220","author":"Sykes","year":"2019","journal-title":"J Infect Dis"},{"key":"2020091011281691300_B42","author":"US Food and Drug Administration","year":"2019"},{"issue":"6 Pt 2","key":"2020091011281691300_B43","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/trf.13587","article-title":"Cognitive evaluation of the AABB Uniform Donor History Questionnaire","volume":"56","author":"Willson","year":"2016","journal-title":"Transfusion"},{"issue":"2","key":"2020091011281691300_B44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/infdis\/jiy011","article-title":"Cumulative antiretroviral exposure measured in hair is not associated with measures of HIV persistence or inflammation among individuals on suppressive ART","volume":"218","author":"Gandhi","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"2020091011281691300_B45","doi-asserted-by":"crossref","first-page":"e0210791","DOI":"10.1371\/journal.pone.0210791","article-title":"Feasibility and acceptability of novel methods to estimate antiretroviral adherence: a longitudinal study","volume":"14","author":"Saberi","year":"2019","journal-title":"PLoS One"},{"key":"2020091011281691300_bib46","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020007003","article-title":"HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men","author":"Grebe","year":"2020","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/11\/1351\/1757560\/bloodbld2020006890.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/11\/1351\/1757560\/bloodbld2020006890.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T16:04:38Z","timestamp":1599753878000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/11\/1351\/461293\/HIV-antiretroviral-therapy-and-prevention-use-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,9,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020006890","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]}}}